PTC Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 11/07/2025 | 8.29 M | $508.70 M | -6.31% | 10.61% |
| RTW INVESTMENTS, LP | 11/14/2025 | 7.75 M | $475.40 M | 0.00% | 9.91% |
| BLACKROCK, INC. | 11/12/2025 | 7.13 M | $437.62 M | -4.67% | 9.12% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2025 | 4.92 M | $301.86 M | 4.78% | 6.29% |
| JANUS HENDERSON GROUP PLC | 11/14/2025 | 3.77 M | $231.69 M | 18.85% | 4.83% |
| ARMISTICE CAPITAL, LLC | 11/17/2025 | 3.28 M | $201.13 M | -30.79% | 4.19% |
| TORONTO DOMINION BANK | 11/14/2025 | 3.25 M | $199.24 M | 32.73% | 4.15% |
| STATE STREET CORP | 11/14/2025 | 3.13 M | $192.38 M | 4.62% | 4.01% |
| D. E. SHAW & CO., INC. | 11/14/2025 | 2.17 M | $133.46 M | -10.79% | 2.78% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 1.95 M | $119.74 M | 0.84% | 2.50% |
| CITADEL ADVISORS LLC | 11/14/2025 | 1.73 M | $106.23 M | 88.05% | 2.22% |
| FMR LLC | 11/13/2025 | 1.61 M | $98.91 M | -6.20% | 2.06% |
| JEFFERIES FINANCIAL GROUP INC. | 11/13/2025 | 1.58 M | $97.25 M | 100.00% | 2.03% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 1.52 M | $93.10 M | 9.82% | 1.94% |
| TANG CAPITAL MANAGEMENT LLC | 11/14/2025 | 1.50 M | $92.06 M | 36.36% | 1.92% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/18/2025 | 1.41 M | $86.21 M | 35.20% | 1.80% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2025 | 1.22 M | $74.91 M | 100.00% | 1.56% |
| FRANKLIN RESOURCES INC | 11/13/2025 | 1.16 M | $71.01 M | -9.24% | 1.48% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 11/14/2025 | 1.13 M | $69.46 M | 6.87% | 1.45% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 1.06 M | $64.84 M | 174.84% | 1.35% |
| HOOD RIVER CAPITAL MANAGEMENT LLC | 11/14/2025 | 995.78 K | $61.11 M | 56.45% | 1.27% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 927.30 K | $56.91 M | -3.74% | 1.19% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 876.41 K | $53.79 M | 12.98% | 1.12% |
| PALO ALTO INVESTORS LP | 11/14/2025 | 862.61 K | $52.94 M | 112.22% | 1.10% |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 11/07/2025 | 800.88 K | $49.15 M | 1.44% | 1.02% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 773.18 K | $47.45 M | 46.60% | 0.99% |
| NORTHERN TRUST CORP | 11/14/2025 | 737.57 K | $45.26 M | -0.22% | 0.94% |
| NUVEEN, LLC | 11/12/2025 | 721.20 K | $44.26 M | -25.56% | 0.92% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 702.76 K | $43.13 M | -0.70% | 0.90% |
| PACER ADVISORS, INC. | 10/15/2025 | 503.97 K | $30.93 M | -31.97% | 0.64% |
| JPMORGAN CHASE & CO | 11/26/2025 | 490.93 K | $30.13 M | -18.39% | 0.63% |
| ROCKEFELLER CAPITAL MANAGEMENT L.P. | 11/14/2025 | 473.76 K | $29.07 M | 2.31% | 0.61% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2025 | 458.33 K | $28.13 M | 1.04% | 0.59% |
| UBS GROUP AG | 11/13/2025 | 452.21 K | $27.75 M | -21.89% | 0.58% |
| BIOIMPACT CAPITAL LLC | 11/14/2025 | 438.48 K | $26.91 M | 0.00% | 0.56% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2025 | 430.93 K | $26.45 M | 27.43% | 0.55% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 11/14/2025 | 425.00 K | $26.08 M | 919.38% | 0.54% |
| MORGAN STANLEY | 11/14/2025 | 419.42 K | $25.74 M | -63.95% | 0.54% |
| LORD, ABBETT & CO. LLC | 11/13/2025 | 378.05 K | $23.20 M | -1.66% | 0.48% |
| BOSTON PARTNERS | 11/13/2025 | 361.66 K | $22.20 M | 100.00% | 0.46% |
| PANAGORA ASSET MANAGEMENT INC | 11/13/2025 | 348.37 K | $21.38 M | 21.78% | 0.45% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2025 | 331.26 K | $20.33 M | -38.33% | 0.42% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 11/13/2025 | 323.55 K | $19.86 M | 851.61% | 0.41% |
| INVESCO LTD. | 11/13/2025 | 313.06 K | $19.21 M | 3.24% | 0.40% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2025 | 291.00 K | $17.86 M | -51.97% | 0.37% |
| ENSIGN PEAK ADVISORS, INC | 11/13/2025 | 288.77 K | $17.72 M | 7.66% | 0.37% |
| VOYA INVESTMENT MANAGEMENT LLC | 10/09/2025 | 284.89 K | $17.48 M | 9.37% | 0.36% |
| IKARIAN CAPITAL, LLC | 11/14/2025 | 280.55 K | $17.22 M | 100.00% | 0.36% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 273.08 K | $16.76 M | 2.59% | 0.35% |
| MAN GROUP PLC | 11/14/2025 | 265.18 K | $16.27 M | -60.51% | 0.34% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
PTC Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 413 institutional investors and hedge funds held shares of PTC Therapeutics, Inc.. The most heavily invested institutionals were:
VANGUARD GROUP INC: 8.29 M
RTW INVESTMENTS, LP: 7.75 M
BlackRock, Inc.: 7.13 M
WELLINGTON MANAGEMENT GROUP LLP: 4.92 M
JANUS HENDERSON GROUP PLC: 3.77 M
ARMISTICE CAPITAL, LLC: 3.28 M
105.88% of PTC Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 101.31 M shares in the last 24 months. This purchase volume represents approximately $7.83 B in transactions.